Background and objectives Dialysis patients show "reverse causality" between serum cholesterol and mortality. No previous studies clearly separated the risk of incident cardiovascular disease (CVD) and the risk of death or fatality after such events. We tested a hypothesis that dyslipidemia increases the risk of incident atherosclerotic CVD and that protein energy wasting (PEW) increases the risk of fatality after CVD events in hemodialysis patients.
Introduction
In the general population, dyslipidemia is one of the established risk factors for coronary heart disease (1,2), and a high body mass index (BMI) is associated with increased cardiovascular risk and mortality (3) . However, the opposite association has been reported between mortality and these risk factors in many populations,including the elderly people (4, 5) , hospitalized patients (6) , patients with chronic heart failure (7), cancer (8) , and advanced stages of chronic kidney disease (CKD) (9 -12) . Such unexpected results in epidemiology are called "risk factor paradox" (13, 14) , "reverse causality," or "reverse epidemiology" (7) .
In dialysis populations, it has been assumed that malnutrition and inflammation promote atherosclerosis (15) , based on the coexistence of malnutrition, inflammation, and atherosclerotic disease (MIA syndrome) (15) . An expert panel (16) recently recommended the term "protein energy wasting" (PEW) rather than "malnutrition" for loss of body protein mass and fuel reserves. The presence of PEW and/or inflammation may explain the paradoxical association between total cholesterol (TC) and mortality risk in dialysis patients, because TC levels are decreased in such conditions (17) . However, there is a large cohort study (18) against the MIA hypothesis showing that dialysis patients with a lower BMI had a lower hazard of hospitalized acute coronary syndrome. Importantly, the MIA hypothesis was based on cardiovascular mortality, whereas the latter cohort study took incident cardiac events as an outcome. Theoretically, the risk of death from cardiovascular disease (CVD) is the product of the risk of an incident CVD event and the risk of death (fatality) after such an event. Fatality rate after incident CVD among CKD patients is substantially higher than those with normal renal function (19 -22) . Thus, the difference in outcome measures may explain the apparent discrepancy between studies and also the reverse epidemiology.
We previously hypothesized that dyslipidemia is a
Statistics
We summarized categorical data as percentages and continuous variables as medians (25th and 75th percentile levels). Correlation between variables was evaluated by Spearman's rank correlation test. Odds ratios (95% confidence intervals) were calculated by logistic regression analysis, and adjustment was performed using multivariate models. P Ͻ 0.05 was considered significant. All these calculations were performed using statistic software JMP version 8.0.1 (SAS Institute Japan, Tokyo, Japan) installed in a Windows personal computer. Table 1 summarizes the baseline characteristics of the cohort. Among the total cohort, 59.1% were men, and 25.5% had diabetic nephropathy. The median levels were 62 years for age, 66 months for duration of hemodialysis, 20.6 kg/m 2 for BMI, 3.9 g/dl for serum albumin, and 0.1 mg/dl for CRP. Median levels of TC, TG, Figure 1 . | Chart of subject selection for this study. From the total subjects in the data set (n ϭ 212,632), we selected patients treated with hemodialysis three times per week whose age was between 20 and 90 years old without previous history of MI, CI, or CB. Patients were excluded when relevant data were not available. The 45,390 subjects were followed-up for 1 year in the database. PD, peritoneal dialysis; HF, hemofiltration; HDF, hemodiafiltration; HA, hemodialysis with hemoadsorption; HD, hemodialysis; DM, diabetes mellitus; S-albumin, serum albumin.
Results

Baseline Characteristics of the Cohort
HDL-C, LDL-C, and non-HDL-C were 157, 96, 45, 88, and 109 mg/dl, respectively. The prevalence of increased TG Ͼ150 and Ͼ200 mg/dl was 20.0 and 8.6%, respectively. LDL-C levels Ͼ100 and Ͼ120 mg/dl were found in 34.2 and 15.5% of the total subjects, respectively. Non-HDL-C levels Ͼ130 and Ͼ150 mg/dl were seen in 28.3 and 14.0%, respectively. Decreased HDL-C levels Ͻ40 mg/dl were found in 35.6%. Table 2 shows correlations between five markers of serum lipids and three markers of PEW and inflammation at baseline. BMI positively correlated with TC, TG, LDL-C, and non-HDL-C but inversely with HDL-C. Serum albumin positively correlated with all of the five lipid variables, particularly with HDL-C. CRP inversely correlated with TC and HDL-C but positively correlated with TG and non-HDL-C. CRP was not significantly correlated with LDL-C.
Clinical Outcomes
Of the 45,390 subjects, 2313 patients died, whereas 43,077 patients were alive after the 1-year follow-up. The size of total observation was 44, 190 Table 3 shows the results of unadjusted logistic regression analysis of predictors of incident MI, incident CI, incident CB, and all-cause mortality.
Univariate Predictors of the Clinical Outcomes
Incident MI was associated with higher age, male gender, diabetes mellitus, short duration of HD, higher BMI, lower serum albumin, and higher CRP levels. Higher TG, lower HDL-C, higher LDL-C, and higher non-HDL-C levels were significant univariate predictors for incident MI, whereas TC was not.
Incident CI was associated with higher age, male gender, diabetes mellitus, shorter duration of HD, lower BMI, lower serum albumin, and higher CRP levels. Lower HDL-C was a significant univaritate predictor of incident CI, whereas TC, TG, LDL-C, and non-HDL-C were not.
Incident CB was associated with higher age, diabetes mellitus, lower serum albumin, and higher CRP. Lower risk of incident CB was associated with higher quartiles (Q3 and Q4) of TG, Q3 of LDL-C, and Q3 of non-HDL-C.
All-cause mortality was associated with higher age, diabetes mellitus, shorter duration of HD, lower BMI, lower serum albumin, and higher CRP levels. Higher TC, TG, HDL-C, LDL-C, and non-HDL-C levels were all significant univariate predictors of lower risk for all-cause mortality. Table 4 shows the association between serum lipids and clinical outcomes by logistic regression analysis adjusted for seven nonlipid variables including age, gender, duration of dialysis, diabetes mellitus, BMI, serum albumin, and CRP.
Adjusted Association of Serum Lipids with Clinical Outcomes
Incident MI was associated with higher TC, TG, LDL-C, and non-HDL-C levels, and lower HDL-C in the multivariate adjusted model. The odds ratio of MI was higher for non-HDL-C than for LDL-C. Figure 2 shows the odds ratios of incident MI for the 4 ϫ 4 categories of HDL-C and non-HDL-C. When the subjects in the highest quartile of HDL-C and the lowest quartile of non-HDL-C were taken as reference, those in the lowest quartile of HDL-C and the highest quartile of non-HDL-C had an odds ratio of 2.91 (1.86 to 4.71) for incident MI.
Incident CI was associated with higher levels of TC, TG, LDL-C, and non-HDL-C, and lower level of HDL-C in the multivariate adjusted model. The odds ratio of non-HDL-C was higher than that of LDL-C, although these associations of lipid parameters with CI were less impressive than their associations with MI.
Incident CB was not significantly associated with TC, HDL-C, or non-HDL-C. Risk of CB showed an inverse association with TG and a U-shaped relationship with LDL-C with the lowest risk in Q3.
Risk of all-cause mortality was again inversely associated with TC and HDL-C but not with TG, LDL-C, or non-HDL-C in the multivariate adjusted model, suggesting that the inverse association between TC and the risk of all-cause death was caused by an increased death risk associated with a low HDL-C. Table 5 summarizes the results of multivariate logistic regression analyses of predictors of clinical outcomes. In these analyses, we intended to look at the impacts of nonlipid variables, particularly of BMI, serum albumin, and CRP, when simultaneously adjusted for both HDL-C and non-HDL-C levels as the lipid variables. In such models, incident MI was associated with higher BMI, lower serum albumin, and higher CRP levels. Incident CI was associated with lower BMI, lower serum albumin, and higher CRP levels. Incident CB was associated with lower serum albumin and higher CRP levels. All-cause mortality was associated with lower BMI, lower serum albumin, and higher CRP levels.
Adjusted Associations of Markers for PEW and Inflammation with Clinical Outcomes
Predictors of Death after CVD Events
Among the patients who experienced incident MI, CI, and/or CB during the follow-up, some patients died, whereas others survived at the end of the follow-up. We examined factors associated with death after such events ( Table 6 ). The significant predictors of death after MI were higher age and lower serum albumin. The significant predictors of death after CI were higher age, longer duration of dialysis, lower BMI, lower serum albumin, and higher CRP levels. The significant predictors of death after CB were lower BMI and higher CRP levels. When the three types of CVD were combined, the predictors of death after the combined CVD events were higher age, lower BMI, and higher CRP levels. Lipid parameters did not predict death after incident CVD.
Discussion
The relative risk of death from CVD was reported to be between 10 and 30 in hemodialysis patients compared with the general population in the United States (31) and Japan (32) . Hemodialysis patients have several times higher risk of incident MI (21) and stroke (20) , but the increased incidence of such events cannot fully explain the extremely elevated risk for death from CVD. The discrepancy between incidence of CVD and mortality rate from CVD indirectly suggests the increased risk of fatality after these vascular events in dialysis patients (13, 14, 33) . In fact, the fatality rate is significantly higher in dialysis patients after acute MI (19, 21) and stroke (20) . Risk factors for incident CVD and those for fatality after CVD event are probably different, and if so, it may explain the reverse epidemiology in dialysis patients. In this context, this study has made the following two novel findings. First, our study clearly showed that the lipid risk factors for incident MI in this cohort of hemodialysis patients were very similar to those in the general population. In multivariate logistic regression models, the risk of incident MI was positively associated with high levels of TC, TG, LDL-C, and non-HDL-C and inversely associated with HDL-C. Compared with the risk of MI, the risk of incident CI was less impressively associated with these lipid variables. These results were consistent with the epidemiology in the general population, indicating that dyslipidemia is an important risk factor for atherosclerotic CVD, particularly for coronary heart disease, even in hemodialysis patients.
Second, this study showed that markers of PEW and inflammation were independent predictors of fatality after vascular events in the dialysis population. We identified BMI, serum albumin, and CRP as the predictors of death after incident vascular disease, although the predictive powers of these markers varied among the types of vascular events. When MI, CI, and CB were combined as incident CVD, lower BMI and higher CRP levels were significant predictors for death among the patients who experienced incident CVD independent of the lipid and other nonlipid variables. Beddhu et al. (18) made similar observations that a low BMI was a predictor of death in hemodialysis patients after acute coronary syndrome. These studies strongly indicate that PEW and inflammation increase the risk of death after CVD by increasing the risk of fatality (13,14) . Although previous studies showed low BMI, low serum albumin, and high CRP levels were predictors for all-cause mortality, it was unknown whether these markers for PEW and inflammation predict incident CVD in the hemodialysis population. This study showed that low serum albumin and high CRP levels were independent predictors of both incident MI and incident CI. Because decline in serum albumin concentration is more closely associated with Among the subjects with incident MI (n ϭ 632), incident CI (n ϭ 1119), incident CB (n ϭ 473), and any of the three (n ϭ 2098), we examined the factors associated with death after these vascular events by univariate and multivariate logistic regression models including the nine factors in the acute phase proteins rather than dietary protein intake in hemodialysis patients (34) , these data may indicate that inflammation was positively associated with incident atherosclerotic CVD in hemodialysis patients. Because BMI correlates positively with both fat mass index and lean mass index in hemodialysis patients (12) , a low BMI serves as an integrated index for PEW. In this study, BMI was positively associated with incident MI and inversely with incident CI. Thus, the impact of PEW on incident CVD seems to depend on the type of vascular disease. We found that a higher level of non-HDL-C or LDL-C was an independent predictor of atherosclerotic CVD in hemodialysis patients. These data may seem to contradict the results of two randomized controlled trials with statin (35, 36 ) that failed to show significant reduction in the composite cardiovascular endpoint in hemodialysis patients. However, the composite cardiovascular endpoints included death from nonatherosclerotic CVD such as congestive heart failure, arrhythmia, and CB. The inclusion of these endpoints must have diluted the true anti-atherosclerotic effects of lipid-lowering. In addition, if a subject received coronary intervention before MI, it was not counted as the primary endpoint, but the secondary endpoint. This must be another cause for underestimating the effects of lipid-lowering. In fact, the risk of ischemic cardiac events including coronary interventions as the second endpoint was significantly reduced by atorvastatin in the 4D trial (35) . Taking these facts into consideration, our results do not conflict with the two randomized control trials.
Our study provides another piece of novel information that non-HDL-C was superior to LDL-C as the lipid predictor of MI in hemodialysis patients. This may not be surprising, because non-HDL-C is the sum of cholesterol in LDL and TG-rich lipoproteins, and both LDL and TGrich lipoproteins are independently associated with atherosclerotic arterial changes in dialysis patients (23) . The better prediction by non-HDL-C than LDL-C was also reported for the general population (37) and in the cohort including type 2 diabetes patients (38, 39) . Non-HDL-C level is an integrated index for atherogenic lipoproteins, and it is not affected by eating (40) . Thus, casual blood non-HDL-C seems to be a lipid variable suitable for assessment of risk for incident atherosclerotic CVD, particularly for coronary heart disease, in hemodialysis patients.
This study has several limitations. First, because we detected the incident vascular disease by looking at the change in the history between the year end of 2003 and 2004, we could not take the time to the event or the time to death after the event into consideration. Second, we did not use fasting serum lipids but casual serum lipid values. This might have brought inaccuracy in calculating LDL-C, although non-HDL-C is not affected by eating. Third, no information was available on medication, BP, pulse rate, and smoking. Statin prescription rate was reported to be 7.1% for Japanese dialysis patients in 2000 (41) . BP is known to show a U-shaped relationship with mortality in dialysis patients (42) . Tachycardia is a predictor of worse outcome in hemodialysis patients (43) . Fourth, it is unknown to what extent these results could be applied to hemodialysis patients living in other countries than Japan, because there are considerable international differences in incidence of cardiovascular disease and serum lipid levels in the general populations. Also, in comparison with the United States and European countries, Japanese dialysis patients have lower levels of serum CRP (44) , BMI (45) , and mortality rates from all-cause (46) and atherosclerotic CVD (47). Thus, these data need to be confirmed in other ethnic groups before being generalized. Finally, the results of this observational cohort study do not necessarily indicate causality as other observational studies.
In conclusion, this study showed a positive association between non-HDL-C and incident vascular disease, especially MI, in a large cohort of hemodialysis patients. Also, higher CRP and lower BMI levels were predictive of higher fatality risk after vascular events. These results indicate the presence of two groups of risk factors contributing to cardiovascular mortality. Further studies are needed to confirm our observations in other ethnic groups.
